Development of Novel Multimodal Dextran-Based Theranostic Tracers: Targeting Fibroblast Activation Protein as Proof of Concept

Información del proyecto

POLYTROP

Identificador del acuerdo de subvención: 101130787

DOI

10.3030/101130787

Proyecto cerrado

Fecha de la firma de la CE 11 Mayo 2023

Fecha de inicio 1 Junio 2023

Fecha de finalización 31 Mayo 2025

Financiado con arreglo a

• Widening participation and spreading excellence

Coste total

Sin datos

Aportación de la UE

€ 169 326,72

Coordinado por

"NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS"""
Greece

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cyclefor all data sets that will be collected, processed or generated by the action. It is adocument describing what data will be collected, processed or generated andfollowing what methodology and standards, whether and how this data will beshared and/or made open, and how it will be curated and preserved.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact ofthe project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and publicengagement strategy, the aim is to inform and reach out to society and show theactivities performed, and the use and the benefits the project will have for citizens.

Publicaciones

Peer reviewed articles (4)

Mixed ligand Re and 99mTc tricarbonyl complexes bearing two important pharmacophores: 2-(4′-aminophenyl)benzothiazole and curcumin

Autores: Alexandros Stouraitis, Marina Sagnou, Barbara Mavroidi, Christos Kiritsis, Antonio Shegani, Catherine Raptopoulou, Vassilis Psycharis, Constantinos Methenitis, Ioannis Pirmettis, Minas Papadopoulos, Maria Pelecanou
Publicado en: Inorganica Chimica Acta, Edición 571, 2024, ISSN 0020-1693
Editor: Elsevier BV
DOI: 10.1016/J.ICA.2024.122172

Synthesis and Biological Evaluation of Novel Cationic Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivative for Epidermal Growth Factor Receptor Targeting

Autores: Sotiria Triantopoulou, Ioanna Roupa, Antonio Shegani, Nektarios N. Pirmettis, Georgia I. Terzoudi, Aristeidis Chiotellis, Maria Tolia, John Damilakis, Ioannis Pirmettis, Maria Paravatou-Petsota
Publicado en: Pharmaceutics, Edición 16, 2024, ISSN 1999-4923
Editor: MDPI AG
DOI: 10.3390/PHARMACEUTICS16091213

Pharmaceutics

Autores: A. Papasavva, N. N. Pirmettis, A. Shegani, E. Papadopoulou, C. Kiritsis, M. Georgoutsou-Spyridonos, D. C. Mastellos, A. Chiotellis, P. Kyprianidou, M. Pelecanou, M. Papadopoulos, I. Pirmettis
Publicado en: Pharmaceutics, 2024, ISSN 1999-4923
Editor: MDPI
DOI: 10.3390/PHARMACEUTICS16091210

Synthesis and characterization of rhenium and Technetium-99 m tricarbonyl and dicarbonyl complexes with quinaldic acid and Arsenic/Phosphorus derivatives

Autores: Charalampos Triantis, Antonio Shegani, Aristeidis Chiotellis, Catherine Raptopoulou, Vassilis Psycharis, Maria Pelecanou, Ioannis Pirmettis, Minas Papadopoulos
Publicado en: Polyhedron, Edición 264, 2024, ISSN 0277-5387
Editor: Elsevier BV
DOI: 10.1016/J.POLY.2024.117236